Before you sell to, join or invest in Altis Biosystems, Inc.
MentionFox check on Altis Biosystems, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/altis-biosystems-inc-form-d-25000001
Check Altis Biosystems, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Altis Biosystems, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Altis Biosystems, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-07.
Altis Biosystems, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 7, 2025. The filing reports $2.13M sold. Its industry group is Biotechnology. It names Christopher Sims (Executive Officer), Susan Mahony (Director), Benjamin Scruggs (Executive Officer, Director) (SEC Form D, April 7, 2025).
Is this your company?
Sell to companies like Altis Biosystems, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Altis Biosystems, Inc.
Free to see. No signup.
More on the people and the money behind Altis Biosystems, Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed in April 2025, largest first.
Get an email when Altis Biosystems, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Altis Biosystems, Inc. raises, hires or launches. No email unless you switch it on.
Watch Altis Biosystems, Inc. →Get the full cited report on Altis Biosystems, Inc.
What the filing shows about Altis Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Altis Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Altis Biosystems, Inc.'s address as 6 Davis Drive, Suite 159, Durham, NC 27709.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Altis Biosystems, Inc. is a registered filer with the SEC (CIK 1799892) and has filed since 2025-04-07. 1 filing is on record, the latest on 2025-04-07.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Altis Biosystems, Inc.'s Form D of 2025-04-07 names Christopher Sims, Susan Mahony, Benjamin Scruggs and 4 more as its officers, directors or promoters.
Its new offerings report $2.13M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
None other than payments of salary in the ordinary course of business to certain of the parties named in response to Item 3.
Christopher Sims is named as Executive Officer on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Susan Mahony is named as Director on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Benjamin Scruggs is named as Executive Officer and Director on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Christopher Perkins is named as Director on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Kevin Causey is named as Director on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Michael Dial is named as Director on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
Jimmy Smedley is named as Executive Officer on the Form D that Altis Biosystems, Inc. filed with the SEC on 7 April 2025, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2025-04-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Altis Biosystems, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Altis Biosystems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Altis Biosystems, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Altis Biosystems, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Altis Biosystems, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Altis Biosystems, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Raleigh-Durham
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/altis-biosystems-inc-form-d-25000001